Switch to: References

Add citations

You must login to add citations.
  1. Paying Human Subjects in Research: Where are We, How Did We Get Here, and Now What?Ari VanderWalde & Seth Kurzban - 2011 - Journal of Law, Medicine and Ethics 39 (3):543-558.
    On November 14, 1996, an in-depth report on the recruiting and testing practices of Lilly Pharmaceuticals appeared in the Wall Street Journal. Laurie Cohen reported that most pharmaceutical companies had difficulty recruiting healthy subjects to participate in testing of “untried and potentially dangerous” drugs. These companies often had to pay subjects up to $250 a day to ensure adequate enrollment, and some even gave referral bonuses to doctors who sent potential subjects their way. Cohen then exposed how Lilly was able (...)
    Download  
     
    Export citation  
     
    Bookmark   7 citations  
  • Paying Human Subjects in Research: Where Are We, How Did We Get Here, and Now What?Ari VanderWalde & Seth Kurzban - 2011 - Journal of Law, Medicine and Ethics 39 (3):543-558.
    Both international and federal regulations exist to ensure that scientists perform research on human subjects in an environment free of coercion and in which the benefits of the research are commensurate with the risks involved. Ensuring that these conditions hold is difficult, and perhaps even more so when protocols include the issue of monetary compensation of research subjects. The morality of paying human research subjects has been hotly debated for over 40 years, and the grounds for this debate have ranged (...)
    Download  
     
    Export citation  
     
    Bookmark   7 citations